“Revance Therapeutics Inc. Securities Fraud Lawsuit: What You Need to Know”
Cohen Milstein Alerts Investors of Complaint Against Revance Therapeutics, Inc. Washington, DC / ACCESS Newswire / January 28, 2025 Cohen Milstein alerts investors that a complaint was filed on January 3, 2025 in the U.S. District Court for the Middle District of Tennessee against Revance Therapeutics, Inc. (“Revance” or the “Company”) (Nasdaq:RVNC), a biotechnology company…